{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:59:29Z","timestamp":1790636369916,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31672581"],"award-info":[{"award-number":["31672581"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.vaccine.2018.12.041","type":"journal-article","created":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T13:45:06Z","timestamp":1547214306000},"page":"839-847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Penton-dodecahedron of fowl adenovirus serotype 4 as a vaccine candidate for the control of related diseases"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5764-8209","authenticated-orcid":false,"given":"Xinglong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuxia","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2441-0026","authenticated-orcid":false,"given":"Zengqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.12.041_b0005","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1099\/vir.0.19497-0","article-title":"Genetic content and evolution of adenoviruses","volume":"84","author":"Davison","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.12.041_b0010","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1128\/CMR.00116-13","article-title":"Adenovirus infections in immunocompetent and immunocompromised patients","volume":"27","author":"Lion","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2018.12.041_b0015","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3201\/eid2204.151403","article-title":"Severe infections with human adenovirus 7d in 2 adults in family, Illinois, USA, 2014","volume":"22","author":"Kajon","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.12.041_b0020","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3390\/v4050847","article-title":"Latest insights on adenovirus structure and assembly","volume":"4","author":"San","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2018.12.041_b0025","series-title":"Proceedings of the National Academy of Sciences of the United States of America","first-page":"11715","article-title":"Structures and organization of adenovirus cement proteins provide insights into the role of capsid maturation in virus entry and infection","author":"Reddy","year":"2014"},{"key":"10.1016\/j.vaccine.2018.12.041_b0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.molcel.2004.11.041","article-title":"The structure of the human adenovirus 2 penton","volume":"17","author":"Zubieta","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.vaccine.2018.12.041_b0035","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0092-8674(93)90231-E","article-title":"Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment","volume":"73","author":"Wickham","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2018.12.041_b0040","doi-asserted-by":"crossref","first-page":"e46075","DOI":"10.1371\/journal.pone.0046075","article-title":"The structural basis for the integrity of adenovirus Ad3 dodecahedron","volume":"7","author":"Szolajska","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.12.041_b0045","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0042-6822(66)90148-6","article-title":"Relationship between the soluble antigens and the virion of adenovirus Type 3. 1.morphological characteristics","volume":"28","author":"The","year":"1966","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.12.041_b0050","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1099\/0022-1317-1-4-553","article-title":"The structure of group II adenoviruses","volume":"1","author":"Gelderblom","year":"1967","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.12.041_b0055","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0042-6822(68)90137-2","article-title":"Comparison between soluble components of adenovirus types 3 and 16 and of the intermediate strain 3\u201316 (the San Carlos Agent) \u2606","volume":"36","author":"Norrby","year":"1968","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.12.041_b0060","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nbt0197-52","article-title":"Adenovirus dodecahedron, a new vector for human gene transfer","volume":"15","author":"Fender","year":"1997","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2018.12.041_b0065","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bej.2012.05.007","article-title":"High-yield and scalable cell-free assembly of virus-like particles by dilution","volume":"67","author":"Liew","year":"2012","journal-title":"Biochem Eng J"},{"key":"10.1016\/j.vaccine.2018.12.041_b0070","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000149946","article-title":"Occurrence of a peculiar type of adenovirus 2 penton oligomer","volume":"7","author":"Boulanger","year":"1976","journal-title":"Intervirology"},{"key":"10.1016\/j.vaccine.2018.12.041_b0075","doi-asserted-by":"crossref","unstructured":"Wilcox WC, Ginsberg HS. Structure of type 5 adenovirus. 1963;118:307\u201314.","DOI":"10.1084\/jem.118.2.307"},{"key":"10.1016\/j.vaccine.2018.12.041_b0080","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1006\/viro.1994.1400","article-title":"Oligomerization of recombinant penton base of adenovirus type 2 and its assembly with fiber in baculovirus-infected cells","volume":"202","author":"Karayan","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.12.041_b0085","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.1128\/JVI.77.8.4960-4964.2003","article-title":"Adenovirus dodecahedron allows large multimeric protein transduction in human cells","volume":"77","author":"Fender","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.12.041_b0090","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/jgm.862","article-title":"Protein transduction into human cells by adenovirus dodecahedron using WW domains as universal adaptors","volume":"8","author":"Garcel","year":"2006","journal-title":"J Gene Med"},{"key":"10.1016\/j.vaccine.2018.12.041_b0095","doi-asserted-by":"crossref","first-page":"e5569-e","DOI":"10.1371\/journal.pone.0005569","article-title":"Adenovirus dodecahedron, as a drug delivery vector","volume":"4","author":"Zochowska","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.12.041_b0100","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1016\/j.vaccine.2009.09.021","article-title":"Influenza recombinant vaccine: matrix protein M1 on the platform of the adenovirus dodecahedron","volume":"27","author":"Naskalska","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.12.041_b0105","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/mt.2010.16","article-title":"In vivo delivery of antigens by adenovirus dodecahedron induces cellular and humoral immune responses to elicit antitumor immunity","volume":"18","author":"Villegas-Mendez","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2018.12.041_b0110","first-page":"362","article-title":"Advances in drug delivery system for platinum agents based combination therapy","volume":"12","author":"Kang","year":"2015","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.vaccine.2018.12.041_b0115","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/03079457608418202","article-title":"Experimental studies on the aetiology of inclusion body hepatitis","volume":"5","author":"Mccracken","year":"1976","journal-title":"Avian Pathol J Wvpa"},{"key":"10.1016\/j.vaccine.2018.12.041_b0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/03079450050045440","article-title":"Detection and differentiation of avian adenoviruses: a review","volume":"29","author":"Hess","year":"2000","journal-title":"Avian Pathol"},{"key":"10.1016\/j.vaccine.2018.12.041_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2017.12.003","article-title":"Immune protection efficacy of FAdV-4 surface proteins fiber-1, fiber-2, hexon and penton base","volume":"245","author":"Wang","year":"2017","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2018.12.041_b0130","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.vaccine.2013.12.056","article-title":"Recombinant FAdV-4 fiber-2 protein protects chickens against hepatitis-hydropericardium syndrome (HHS)","volume":"32","author":"Schachner","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.12.041_b0135","first-page":"e103","article-title":"Isolation and molecular characterization of prevalent Fowl adenovirus strains in southwestern China during 2015\u20132016 for the development of a control strategy","volume":"6","author":"You","year":"2017","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2018.12.041_b0140","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.vetmic.2016.11.005","article-title":"Characterization of fowl adenoviruses isolated between 2007 and 2014 in China","volume":"197","author":"Changjing","year":"2016","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2018.12.041_b0145","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12985-016-0644-x","article-title":"Molecular epidemiology of hydropericardium syndrome outbreak-associated serotype 4 fowl adenovirus isolates in central China","volume":"13","author":"Zhang","year":"2016","journal-title":"Virology J"},{"key":"10.1016\/j.vaccine.2018.12.041_b0150","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1016\/j.vaccine.2014.03.015","article-title":"An inactivated oil-emulsion fowl Adenovirus serotype 4 vaccine provides broad cross-protection against various serotypes of fowl Adenovirus","volume":"32","author":"Kim","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.12.041_b0155","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/BF02633014","article-title":"Hydropericardium syndrome (HPS) in India: a preliminary study on the causative agent and control of the disease by inactivated autogenous vaccine","volume":"29","author":"Kumar","year":"1997","journal-title":"Trop Anim Health Prod"},{"key":"10.1016\/j.vaccine.2018.12.041_b0160","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/03079459008418721","article-title":"Experimental transmission of hydropericardium syndrome and protection against it in commercial broiler chickens","volume":"19","author":"Anjum","year":"1990","journal-title":"Avian Pathol"},{"key":"10.1016\/j.vaccine.2018.12.041_b0165","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1637\/8999-072309-Reg.1","article-title":"Specific-pathogen-free chickens vaccinated with a live FAdV-4 vaccine are fully protected against a severe challenge even in the absence of neutralizing antibodies","volume":"54","author":"Schonewille","year":"2010","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2018.12.041_b0170","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11250-010-9694-z","article-title":"Preparation and evaluation of chicken embryo-adapted fowl adenovirus serotype 4 vaccine in broiler chickens","volume":"43","author":"Mansoor","year":"2011","journal-title":"Trop Anim Health Prod"},{"key":"10.1016\/j.vaccine.2018.12.041_b0175","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1016\/j.vaccine.2017.03.075","article-title":"Immunogenicity and protective efficacy of virus-like particles and recombinant fiber proteins in broiler-breeder vaccination against fowl adenovirus (FAdV)-8b","volume":"35","author":"Gupta","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.12.041_b0180","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3347\/kjp.2013.51.2.247","article-title":"Generation and immunity testing of a recombinant adenovirus expressing NcSRS2-NcGRA7 fusion protein of bovine Neospora caninum","volume":"51","author":"Jia","year":"2013","journal-title":"Kor J Parasitol"},{"key":"10.1016\/j.vaccine.2018.12.041_b0185","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.vetimm.2011.11.014","article-title":"Adenovirus-based oral vaccine for rabbit hemorrhagic disease","volume":"145","author":"Wang","year":"2012","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2018.12.041_b0190","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.01005","article-title":"Different dynamic distribution in chickens and ducks of the hypervirulent, novel genotype fowl adenovirus Serotype 4 recently emerged in China","volume":"8","author":"Pan","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2018.12.041_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2017.12.003","article-title":"Immune protection efficacy of FAdV-4 surface proteins fiber-1, fiber-2, hexon and penton base","volume":"245","author":"Wang","year":"2018","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2018.12.041_b0200","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/jir.2017.0043","article-title":"Coadministration of recombinant adenovirus expressing GM-CSF with inactivated H5N1 avian influenza vaccine increased the immune responses and protective efficacy against a wild bird source of H5N1 challenge","volume":"37","author":"Wang","year":"2017","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.vaccine.2018.12.041_b0205","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/1566523213666131125095046","article-title":"Adenovirus vectors for gene therapy, vaccination and cancer gene therapy","volume":"13","author":"Wold","year":"2013","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.vaccine.2018.12.041_b0210","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.virol.2014.03.010","article-title":"E1B and E4 oncoproteins of adenovirus antagonize the effect of apoptosis inducing factor","volume":"456\u2013457","author":"Turner","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.12.041_b0215","first-page":"-","article-title":"Adenovirus vector production and purification","volume":"10","author":"Silva","year":"2010","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.vaccine.2018.12.041_b0220","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1099\/0022-1317-2-1-135","article-title":"Comparison of soluble components of adenovirus types 3 and 11","volume":"2","author":"Norrby","year":"1968","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.12.041_b0225","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.virol.2005.06.030","article-title":"Synthesis, cellular localization, and quantification of penton-dodecahedron in serotype 3 adenovirus-infected cells","volume":"340","author":"Fender","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.12.041_b0230","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.virol.2004.01.015","article-title":"Heparan sulfate proteoglycan mediates the selective attachment and internalization of serotype 3 human adenovirus dodecahedron","volume":"321","author":"Viv\u00e8s","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.12.041_b0235","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.virol.2007.09.026","article-title":"Adenovirus dodecahedron cell attachment and entry are mediated by heparan sulfate and integrins and vary along the cell cycle","volume":"371","author":"Fender","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.12.041_b0240","doi-asserted-by":"crossref","first-page":"e2257","DOI":"10.1371\/journal.pone.0002257","article-title":"Efficacious recombinant influenza vaccines produced by high yield bacterial expression: a solution to global pandemic and seasonal needs","volume":"3","author":"Song","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.12.041_b0245","doi-asserted-by":"crossref","first-page":"e5569","DOI":"10.1371\/journal.pone.0005569","article-title":"Adenovirus dodecahedron, as a drug delivery vector","volume":"4","author":"Zochowska","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.12.041_b0250","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.vaccine.2013.12.056","article-title":"Recombinant FAdV-4 fiber-2 protein protects chickens against hepatitis\u2013hydropericardium syndrome (HHS)","volume":"32","author":"Schachner","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.12.041_b0255","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.1016\/j.vaccine.2012.10.013","article-title":"A subunit vaccine against hydropericardium syndrome using adenovirus penton capsid protein","volume":"30","author":"Shah","year":"2012","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18317146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18317146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:33:51Z","timestamp":1573691631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18317146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0264410X18317146"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.12.041","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/394072","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Penton-dodecahedron of fowl adenovirus serotype 4 as a vaccine candidate for the control of related diseases","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.12.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}